Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
9.29%
↓ 28% below average
Average (39q)
12.89%
Historical baseline
Range
High:71.70%
Low:-16.34%
Volatility
683.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 9.29% |
| Q2 2025 | 23.50% |
| Q1 2025 | -16.34% |
| Q4 2024 | 5.79% |
| Q3 2024 | 11.72% |
| Q2 2024 | 14.73% |
| Q1 2024 | -4.07% |
| Q4 2023 | 11.19% |
| Q3 2023 | 9.52% |
| Q2 2023 | 9.54% |
| Q1 2023 | -2.07% |
| Q4 2022 | 7.84% |
| Q3 2022 | 1.19% |
| Q2 2022 | 2.56% |
| Q1 2022 | -4.19% |
| Q4 2021 | 3.28% |
| Q3 2021 | 2.75% |
| Q2 2021 | 16.58% |
| Q1 2021 | -5.91% |
| Q4 2020 | 4.65% |
| Q3 2020 | 8.15% |
| Q2 2020 | 3.02% |
| Q1 2020 | 9.46% |
| Q4 2019 | 13.38% |
| Q3 2019 | 10.51% |
| Q2 2019 | 29.62% |
| Q1 2019 | 4.29% |
| Q4 2018 | 58.50% |
| Q3 2018 | -3.35% |
| Q2 2018 | 27.63% |
| Q1 2018 | 13.35% |
| Q4 2017 | 35.45% |
| Q3 2017 | 51.91% |
| Q2 2017 | 71.70% |
| Q1 2017 | 47.26% |
| Q4 2016 | 33.10% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |